Breaking News Instant updates and real-time market news.

CMG

Chipotle

$804.00

17.19 (2.18%)

, LN

Line Corp.

$47.32

(0.00%)

10:09
11/26/19
11/26
10:09
11/26/19
10:09

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chipotle (CMG) upgraded to Outperform from Market Perform at Cowen with analyst Andrew Charles saying he sees upside to expectations for the company's comps and earnings from the growth of its digital sales, growing consumer trend calling for food transparency, higher advertising budget, and the success of its loyalty program. 2. Line Corp. (LN) upgraded to Hold from Underperform at Jefferies. 3. Dynex Capital (DX) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Eric Hagen saying with both nominal and option-adjusted agency mortgage-backed security spreads wide, it is "hard to overlook" Dynex's attractive valuation. 4. MAA (MAA) upgraded to Sector Perform from Underperform at Scotiabank. 5. Bluebird Bio (BLUE) upgraded to Outperform from Market Perform at SVB Leerink with analyst Mani Foroohar noting the stock has fallen 51% since early March. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CMG

Chipotle

$804.00

17.19 (2.18%)

LN

Line Corp.

$47.32

(0.00%)

DX

Dynex Capital

$17.05

0.48 (2.90%)

MAA

MAA

$135.28

1.26 (0.94%)

BLUE

Bluebird Bio

$77.90

3.1 (4.14%)

  • 07

    Dec

CMG Chipotle
$804.00

17.19 (2.18%)

11/18/19
WBLR
11/18/19
NO CHANGE
WBLR
Market Perform
Chipotle checks show price hikes similar to last year, says William Blair
William Blair analyst Sharon Zackfia says that based on her weekly analysis, Chipotle Mexican Grill raised prices in six of the 10 markets she tracked this week, with the most pronounced increases on guacamole, sides, and beverages. The current price increase is rolling out a bit earlier than last year's early-December price increase, which conversely focused more on entrees, Zackfia tells investors in a research note. She believes the current round of price increases is already likely contemplated in consensus estimates. However, Zackfia increased her Q4 and Q1 estimates given the extension of carne asada through at least the first quarter as she believes carne asada was a material contributor to Chipotle's comp acceleration in late September that continued into October. Nonetheless, she keeps a Market Perform rating on the shares, seeing "already-elevated consensus expectations."
11/26/19
COWN
11/26/19
UPGRADE
Target $970
COWN
Outperform
Chipotle upgraded to Outperform from Market Perform at Cowen
Cowen analyst Andrew Charles upgraded Chipotle to Outperform from Market Perform with a price target of $970, up from $800. The analyst sees upside to expectations for the company's comps and earnings from the growth of its digital sales, growing consumer trend calling for food transparency, higher advertising budget, and the success of its loyalty program. Charles adds that Chipotle brand should grow even faster with the launch of the drive-thru option starting in 2021.
11/20/19
PIPR
11/20/19
NO CHANGE
Target $904
PIPR
Overweight
Chipotle recent pullback a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Nicole Miller Regan views the recent pullback in shares of Chipotle Mexican Grill as a buying opportunity. The company's comp momentum continues, and therefore a buying opportunity exists, Regan tells investors in a research note. Based on both recent conversations and channel checks, the analyst raised her Q4 same-store sales estimate for Chipotle by 200 basis points to 10%. She reiterates an Overweight rating on the shares with a $904 price target.
11/26/19
COWN
11/26/19
UPGRADE
Target $970
COWN
Outperform
Chipotle upgraded to Outperform from Market Perform at Cowen
Cowen analyst Andrew Charles upgraded Chipotle Mexican Grill to Outperform from Market Perform with a price target pf $970, up from $800.
LN Line Corp.
$47.32

(0.00%)

11/26/19
JEFF
11/26/19
UPGRADE
Target $5200
JEFF
Hold
Line Corp. upgraded to Hold from Underperform at Jefferies
Jefferies analyst Atul Goyal upgraded Line Corp. to Hold from Underperform with a 5,200 yen price target.
06/24/19
GSCO
06/24/19
UPGRADE
GSCO
Neutral
Line Corp. upgraded to Neutral from Sell at Goldman Sachs
06/24/19
GSCO
06/24/19
UPGRADE
GSCO
Neutral
Line Corp. now fairly valued, upgraded to Neutral at Goldman Sachs
Goldman Sachs analyst Masaru Sugiyama upgraded Line Corp to Neutral from Sell with a Y2,700 price target, saying the stock has declined 24% since being added to the firm's Sell list in February and thinks it is now fairly valued. In a research note to investors, Sugiyama also says Line's enterprise value looks reasonable and believes cash burn in new businesses will ease. Looking ahead, the analyst expects announcements of new businesses at Line's business strategy conference on June 27, especially in the fintech space.
09/11/19
FBCO
09/11/19
UPGRADE
FBCO
Neutral
Line Corp. upgraded to Neutral from Underperform at Credit Suisse
DX Dynex Capital
$17.05

0.48 (2.90%)

11/25/19
KBWI
11/25/19
UPGRADE
Target $17.5
KBWI
Outperform
Dynex Capital upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Eric Hagen upgraded Dynex Capital to Outperform from Market Perform with a price target of $17.50, up from $15. With both nominal and option-adjusted agency mortgage-backed security spreads wide, it is "hard to overlook" Dynex's attractive valuation, Hagen tells investors in a research note. Management's "solid" track record of repurchasing stock below book value supports the valuation, adds the analyst.
03/26/19
NOMU
03/26/19
INITIATION
Target $7
NOMU
Buy
Dynex Capital initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Matthew Howlett started Dynex Capital with a Buy rating and $7.00 price target. The analyst believes the company should grow its core earnings and economic return above its peers and finds the stock inexpensive at current levels. He also initiated coverage of the U.S. Mortgage REITs industry with a positive outlook. The environment for levered mortgage-based operating models is the best it's been since the Taper Tantrum, Howlett tells investors in a research note. He thinks the space is poised to attract interest from "yield-starved investors amid a low, range-bound interest rate environment and expected yield curve steepening."
05/02/19
LTCO
05/02/19
DOWNGRADE
LTCO
Neutral
Ladenburg downgrades Dynex Capital on less certain dividend outlook
Ladenburg Thalmann analyst Christopher Nolan downgraded Dynex Capital to Neutral from Buy without a price target following the company's Q1 results. The analyst believes the company's dividend outlook is becoming less certain. He's cautious on further spread compression in Q2 and as a result, reduced his dividend outlook. Nolan estimates Dynex's new equity will need to be levered above 9.5 times to cover the dividend.
05/02/19
LTCO
05/02/19
DOWNGRADE
LTCO
Neutral
Dynex Capital downgraded to Neutral from Buy at Ladenburg
MAA MAA
$135.28

1.26 (0.94%)

11/08/19
GSCO
11/08/19
INITIATION
Target $149
GSCO
Neutral
MAA initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Richard Skidmore initiated coverage of MAA with a Neutral rating and $149 price target. The analyst started 10 residential real estate investment trusts. Favorable demographic trends, limited disruption threat and strong cash and dividend characteristics drive his positive long-term view of the sector. Skidmore expects MAA's forward funds from operations growth will be in line with Residential REITs.
11/26/19
SCOT
11/26/19
UPGRADE
Target $138
SCOT
Sector Perform
MAA upgraded to Sector Perform from Underperform at Scotiabank
Scotiabank analyst Trent Trujillo upgraded MAA to Sector Perform from Underperform with a $138 price target.
11/04/19
SOCO
11/04/19
UPGRADE
Target $147
SOCO
Overweight
MAA upgraded to Overweight from Equalweight at Capital One
Capital One analyst Neil Malkin upgraded MAA to Overweight from Equalweight with a price target of $147, up from $130.
11/07/19
MZHO
11/07/19
DOWNGRADE
Target $50
MZHO
Neutral
UDR, Inc. downgraded to Neutral from Buy at Mizuho
Mizuho analyst Haendel St. Juste downgraded UDR, Inc. (UDR) to Neutral from Buy with a $50 price target. The stock trades at its "highest multiple ever with little room for further multiple expansion," and the company faces supply headwinds in many of its core markets, St. Juste tells investors in a research note. As such, the analyst is "taking a chip off the table." He sees better relative risk- and growth-adjusted value in Aimco (AIV), MAA (MAA) and Camden Property Trust (CPT).
BLUE Bluebird Bio
$77.90

3.1 (4.14%)

11/26/19
LEER
11/26/19
UPGRADE
Target $119
LEER
Outperform
Bluebird Bio upgraded to Outperform from Market Perform at SVB Leerink
SVB Leerink analyst Mani Foroohar upgraded Bluebird Bio to Outperform from Market Perform with a $119 price target.
11/19/19
EVER
11/19/19
DOWNGRADE
Target $86
EVER
In Line
Bluebird Bio downgraded to In Line at Evercore ISI
As previously reported, Evercore ISI analyst Joshua Schimmer downgraded Bluebird Bio to In Line from Outperform with a price target of $86, down from $172. The analyst said Bluebird continues to spend heavily on SG&A and R&D and is steering its lentivirus platform more towards the crowded and challenging cancer therapeutics field and away from traditional monogenic diseases.
11/19/19
EVER
11/19/19
DOWNGRADE
Target $86
EVER
In Line
Bluebird Bio downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Joshua Schimmer downgraded Bluebird Bio to In Line from Outperform with an $86 price target.
11/26/19
LEER
11/26/19
UPGRADE
Target $119
LEER
Outperform
Bluebird Bio upgraded to Outperform after 51% pullback at SVB Leerink
As previously reported, SVB Leerink analyst Mani Foroohar upgraded Bluebird Bio to Outperform from Market Perform with an unchanged $119 price target, noting that the stock has fallen 51% since early March. The gradual pace of the Zynteglo launch is now fully appreciated by investors and competitive threats to bb2121 are now reflected in the stock price, said Foroohar, who notes that the stock is now trading just below his estimated value of $77 per share if zero value is attributed to its B-cell maturation antigen business. However, this implies an unreasonable scenario in which bb2121 and bb21217 fail entirely, which is in "stark contrast to the state of the BCMA race suggested by data to date," Foroohar tells investors. He sees an attractive risk/reward into BCMA data and filing through early 2020, the analyst added.

TODAY'S FREE FLY STORIES

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

, CMCSA

Comcast

$43.59

0.57 (1.33%)

07:44
12/14/19
12/14
07:44
12/14/19
07:44
Periodicals
Berkshire, Anthem among Barron's top 10 stock picks for 2020 »

Barron's has…

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

RDS.B

Royal Dutch Shell

$57.41

-0.19 (-0.33%)

RDS.A

Royal Dutch Shell

$57.44

-0.32 (-0.55%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

VIAC

ViacomCBS

$38.62

0.83 (2.20%)

ANTM

Anthem

$284.14

-0.405 (-0.14%)

DELL

Dell Technologies

$49.39

-0.11 (-0.22%)

GOOG

Alphabet

$1,348.07

-2.09 (-0.15%)

GOOGL

Alphabet Class A

$1,347.11

-1.4 (-0.10%)

UHAL

Amerco

$360.28

7.57 (2.15%)

UTX

United Technologies

$148.99

-0.5 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Feb

PCG

PG&E

$11.26

-0.49 (-4.17%)

07:38
12/14/19
12/14
07:38
12/14/19
07:38
Hot Stocks
California Governor says PG&E restructuring plan 'falls woefully short' »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

MYGN

Myriad Genetics

$25.58

0.58 (2.32%)

07:31
12/14/19
12/14
07:31
12/14/19
07:31
Hot Stocks
Myriad Genetics says study validates polygenic risk score for breast cancer »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPC

Tutor Perini

$15.73

-0.17 (-1.07%)

07:30
12/14/19
12/14
07:30
12/14/19
07:30
Hot Stocks
Tutor Perini 'disappointed,' will appeal jury verdict in SR 99 Alaskan Way case »

Tutor Perini released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

, BD

Budget Group

$0.00

(0.00%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
European Society for Medical Oncology to hold a conference »

ESMO Immuno-Oncology…

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

BD

Budget Group

$0.00

(0.00%)

IDRA

Idera Pharmaceuticals

$1.59

-0.05 (-3.05%)

MRK

Merck

$89.18

0.84 (0.95%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

NKTR

Nektar

$21.28

-0.53 (-2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ATNX

Athenex

$14.56

-2.38 (-14.05%)

, MRK

Merck

$89.18

0.84 (0.95%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Society of Surgical Oncology to hold a symposium »

San Antonio Breast Cancer…

ATNX

Athenex

$14.56

-2.38 (-14.05%)

MRK

Merck

$89.18

0.84 (0.95%)

ONCS

OncoSec

$2.00

-0.39 (-16.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

, CRON

Cronos Group

$7.28

-0.03 (-0.41%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
MJBizDaily to hold a conference »

Marijuana Business…

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

CRON

Cronos Group

$7.28

-0.03 (-0.41%)

NFX

Newfield Exploration

$0.00

(0.00%)

CGC

Canopy Growth

$20.69

-0.455 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDSI

BioDelivery Sciences

$6.40

-0.065 (-1.01%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
BioDelivery Sciences management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

, AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

BBSI

Barrett Business

$93.18

1.82 (1.99%)

BNGO

Bionano Genomics

$1.02

0.01 (0.99%)

IRMD

iRadimed

$25.25

-0.52 (-2.02%)

FC

Franklin Covey

$35.21

-0.57 (-1.59%)

NBEV

New Age Beverages

$1.91

-0.015 (-0.78%)

WATT

Energous

$1.99

(0.00%)

EAST

Eastside Distilling

$2.79

-0.12 (-4.12%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.89

0.64 (1.22%)

CLAR

Clarus

$13.47

-0.02 (-0.15%)

JRSH

Jerash Holdings

$6.46

(0.00%)

MCHX

Marchex

$3.68

0.03 (0.82%)

JYNT

Joint Corp.

$17.37

0.28 (1.64%)

SOLY

Soliton

$10.35

-0.005 (-0.05%)

SMSI

Smith Micro

$4.66

0.095 (2.08%)

PWFL

PowerFleet

$6.10

0.05 (0.83%)

OSIS

OSI Systems

$100.60

0.63 (0.63%)

LOVE

Lovesac

$10.80

-1.01 (-8.55%)

VERI

Veritone

$2.73

-0.1 (-3.53%)

WTER

Alkaline Water

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

, LEA

Lear

$129.43

-0.84 (-0.64%)

17:22
12/13/19
12/13
17:22
12/13/19
17:22
Hot Stocks
Grand Canyon, Lear to replace Oasis, Southwestern in S&P 400 at open on 12/23 »

Grand Canyon Education…

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

RTN

Raytheon

$217.31

-0.93 (-0.43%)

17:20
12/13/19
12/13
17:20
12/13/19
17:20
Hot Stocks
Raytheon awarded $123.53M Navy contract modification »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.